[Absorption and excretion as well as clinical evaluation of clindamycin-2-palmitate in pediatric field (author's transl)].
D000284:Administration, Oral; D001249:Asthma / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002981:Clindamycin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007677:Kidney Function Tests; D008111:Liver Function Tests; D008297:Male; D010169:Palmitic Acids / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D011014:Pneumonia / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012541:Scarlet Fever / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D014069:Tonsillitis / Q000188:drug therapy
D010169:Palmitic Acids; D002981:Clindamycin